促进认知衰退的社会参与:对干预有效性和行为改变机制的系统审查和元分析
Shuyan Fang1, Wei Li2, Shengze Zhi1
1School of Nursing, Jilin University, Jilin, People's Republic of China.
Worldviews on evidence-based nursing
|July 18, 2025
概括
音乐和回忆疗法等社会参与干预措施可以改善认知衰退患者的参与度. 团体格式特别有效,但对于早期阶段需要更多的研究.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 康复科学 康复科学 康复科学
背景情况:
- 认知衰退 (SCD,MCI,痴呆症) 损害了社会参与,导致孤立和生活质量下降.
- 加强社会参与的干预措施至关重要,但关于有效性和机制的证据不一致.
研究的目的:
- 评估认知能力下降的个人的社会参与干预措施.
- 识别有效的行为改变技术 (BCT),以支持社会参与.
主要方法:
- 在2024年10月之前,对8个数据库进行系统搜索.
- 使用Cochrane偏差风险工具进行质量评估;与审查经理5.4和Stata18进行元分析.
- 使用GRADE方法对证据的确定性进行评分.
主要成果:
- 包括16个RCT (2190名参与者). 音乐治疗 (SMD=0.62) 和回忆疗法 (SMD=0.34) 显示出显著的积极效果.
- 基于小组的干预措施是有效的 (SMD=0.23). 共同的BCT:目标设定,实践,社会支持.
- 异质性和关于SCD/MCI的有限数据限制了概括性.
结论:
- 音乐治疗,回忆疗法和小组形式可能会增强认知衰退的社会参与.
- 社交互动需要复杂的认知功能,对有障碍的老年人来说具有挑战性.
- 需要进一步的研究来优化早期认知衰退阶段的干预措施.
更多相关视频
07:01Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
4.9K
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.4K
相关概念视频
Cognitive Development During Adulthood
288
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
288
Community Based Intervention
95
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
95
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
209
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
209
Social Facilitation
33.0K
Not all intergroup interactions lead to negative outcomes. Sometimes, being in a group situation can improve performance. Social facilitation occurs when an individual performs better when an audience is watching than when the individual performs the behavior alone. This typically occurs when people are performing a task for which they are skilled.
33.0K
Autism Spectrum Disorder
339
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
339
Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
